Application of Color Doppler Ultrasound Combined with Fibroscan Scoring System in the Diagnosis of Chronic Hepatitis B Fibrosis

doi:10.7517/issn.1674-0475.200711

Abstract

Abstract: To explore the application value of color Doppler ultrasound combined with Fibroscan scoring system in the diagnosis of chronic hepatitis B fibrosis, a total of 300 patients with chronic hepatitis B undergoing ultrasound-guided liver biopsy were selected, among which 235 patients had liver fibrosis (observation group) and 65 patients didn't have liver fibrosis (control group). The color Doppler ultrasound parameters[including main portal vein diameter (mPVD), splenic vein diameter (SVD), main portal vein blood flow (mPBF), mean velocity of main portal vein (mPVm), portal vein congestion index (CI), mean velocity of splenic vein (sVm), splenic vein blood flow (sVBF)] and liver stiffness measurement (LSM) of two groups were statistically analyzed, as well as the parameters between different liver fibrosis stages. The results showed that the AUC of combined diagnosis of CHB liver fibrosis was the highest, which was 0.876 (P<0.05). SVD, mPVD, CI, LSM were positively correlated with liver fibrosis stage, mPVm was negatively correlated with liver fibrosis stage (P<0.05). The AUC of liver fibrosis stage diagnosed by LSM was the largest (P<0.05). It can be seen that using color Doppler ultrasound and FibroScan directional instantaneous elastography system, which detected SVD, mPVD, CI, mPVm, and LSM, can effectively diagnose CHB liver fibrosis. And each parameter is closely related to the degree of liver fibrosis. The combined detection is expected to be a non-invasive method for evaluating liver fibrosis and severity.

Key words: color Doppler ultrasound, Fibroscan scoring system, chronic hepatitis B, liver fibrosis, splenic vein, portal vein, ROC

XU Yicai, WU Yanhui, ZHANG Ran, LIU Cuiping, WU Yunzhe. Application of Color Doppler Ultrasound Combined with Fibroscan Scoring System in the Diagnosis of Chronic Hepatitis B Fibrosis[J]. IMAGING SCIENCE AND PHOTOCHEMISTRY, 2021, 39(1): 67-74.

References

[1] Cao X, Shang Q H, Chi X L, et al. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus[J]. World Journal of Gastroenterology, 2020, 26(10):1067-1079.
[2] Tan-Garcia A, Lai F, Sheng Y J P, et al. Liver fibrosis and CD206+ macrophage accumulation are suppressed by anti-GM-CSF therapy[J]. JHEP Reports, 2019, 2(1):100062.
[3] Nahon P, Ganne-Carrié N. Management of patients with pre-therapeutic advanced liver fibrosis following HCV eradication[J]. JHEP Reports, 2019, 1(6):480-489.
[4] Ni L, Li C, Li Y. Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and comparison in chronic hepatitis B, liver cirrhosis and liver cancer[J]. Oncology Letters, 2020, 19(3):2562-2567.
[5] Yan L T, Wang L L, Yao J, et al. Total bile acid-to-cholesterol ratio as a novel noninvasive marker for significant liver fibrosis and cirrhosis in patients with non-cholestatic chronic hepatitis B virus infection[J]. Medicine (Baltimore), 2020, 99(8):e19248.
[6] Newsome P N, Sasso M, Deeks J J, et al. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis:a prospective derivation and global validation study[J]. The Lancet Gastroenterology & Hepatology, 2020, 5(4):362-373.
[7] Xue L Y, Jiang Z Y, Fu T T, et al. Transfer learning radiomics based on multimodal ultrasound imaging for staging liver fibrosis[J]. European Radiology, 2020, 30(5):2973-2983.
[8] Jain V, Poddar U, Negi T S, et al. Utility and accuracy of transient elastography in determining liver fibrosis:a case-control study[J]. European Journal of Pediatrics, 2020, 179(4):671-677.
[9] Terrault N A, Lok A S F, McMahon B J, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B:AASLD 2018 hepatitis B guidance[J]. Clinical Liver Disease(Hoboken), 2018, 12(1):33-34.
[10] 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会. 肝纤维化诊断及治疗共识(2019年)[J]. 实用肝脏病杂志, 2019, 22(6):793-803.
[11] Yalaki S, Yalcin M S. Does regression in treatment-induced liver fibrosis reflect noninvasive tests? Assessing treatment results of hepatitis B patients who took potent antiviral drugs for 5 years[J]. Nigerian Journal of Clinical Practice, 2020, 23(2):226-231.
[12] 闫瑞斌, 马淑梅, 卓玛, 等. 慢性乙型肝炎患者血清MMP-2和TIMP-2水平及超声检查指标评估肝纤维化分期意义探讨[J]. 实用肝脏病杂志, 2019, 22(4):506-509.
[13] 翟亚楠, 雷军强, 郭顺林, 等. 钆塞酸二钠多期动态增强扫描和磁共振弥散成像对早期肝纤维化评估价值的对比研究[J]. 临床放射学杂志, 2018, 37(10):1739-1744.
[14] 张岚, 朱海云. Exchange模型的DCE-MRI定量研究评价肝纤维化的价值[J]. 中国医学计算机成像杂志, 2018, 24(2):137-142.
[15] Chetcuti Z S, Chircop A, Cortis K, et al. Hepatobiliary and pancreatic:congenital intrahepatic portosystemic venous shunting:a great mimicker of liver cirrhosis[J]. Journal of Gastroenterology & Hepatology, 2016, 31(12):1917.
[16] 高德军, 罗鹰, 陈首名, 等. 双源CT门静脉成像在肝硬化门静脉侧支循环的临床应用[J]. 中国CT和MRI杂志, 2019, 17(8):100-102, 106.
[17] Xie X, Feng Y, Lyu Z, et al. Liver stiffness as measured by two-dimensional shear wave elastography overestimates the stage of fibrosis in patients with chronic hepatitis B and hepatic steatosis[J]. Clinics and Research in Hepatology and Gastroenterology, 2020. https://doi.org/10.1016/j.clinre.2020.03.021.
[18] Mendoza Y, Cocciolillo S, Murgia G, et al. Noninvasive markers of portal hypertension detect decompensation in overweight or obese patients with compensated advanced chronic liver disease[J]. Clinical Gastroenterology and Hepatology, 2020, 18(13):3017-3025.
[19] Sripongpun P, Tangkijvanich P, Chotiyaputta W, et al. Evaluation of aspartate aminotransferase to platelet ratio index and fibrosis 4 scores for hepatic fibrosis assessment compared with transient elastography in chronic hepatitis C patients[J]. JGH Open, 2019, 4(1):69-74.
[20] Xie L T, Gu J H, Chai W L, et al. Pre-operative detection of liver fibrosis in hepatocellular carcinoma patients using 2D shear wave elastography:where to measure[J]. Ultrasound in Medicine & Biology, 2020, 46(6):1412-1423.
[21] Wu M, Wu L, Jin J, et al. Liver stiffness measured with two-dimensional shear-wave elastography is predictive of liver-related events in patients with chronic liver disease due to Hepatis B viral infection[J]. Radiology, 2020, 295(2):353-360.
[22] Ye J T, Wang W, Feng S T, et al. Precise fibrosis staging with shear wave elastography in chronic hepatitis B depends on liver inflammation and steatosis[J]. Hepatology International, 2020, 14(2):190-201.